May 2024
5
• Expand access to high quality, evidence-based, low-barrier health care for people who use drugs
• Increase equitable access to buprenorphine and MAUD treatment and comprehensive health care for
people who use drugs
• Support primary care providers and nurses in caring for people who use drugs
• Reduce stigma around drug use, people who use drugs, and evidence-based care for people who use
drugs
Program Information
All human service programs funded by the NYC Health Department will be expected to describe and implement
organizational strategies and approaches to racial equity and social justice through programming and
operations, ensuring that services are equitable and responsive to the program participants’ needs to address
racial health gaps and improve health outcomes for all New York City residents. For more information regarding
racial equity and social justice please visit https://www1.nyc.gov/site/doh/health/health-topics/race-to-
justice.page."
a. Service Delivery
Selected contractors will be expected to provide services as indicated to all patients who use drugs, ranging from
patients who are not experiencing problematic use to patients with opioid use disorder, alcohol use disorder,
and/or other substance use disorders.
1. Service delivery model: Contractors will be expected to operate within the framework of the Nurse Care
Manager model. This model embodies collaborative care management of substance use disorders with
an emphasis on the integration of low-barrier, evidence-based medication treatment for opioid use
disorder into primary care. In this model, a dedicated RN-level Nurse Care Manager (NCM) provides
structured clinical support to primary care providers. Together, the NCM and PCP will screen and assess
patients; provide medication management, motivational counseling, follow-up care, and monitoring;
and refer patients to additional health care and supportive services as necessary.
2. Health Care Services: Contractors will be expected to use the NCM model and team-based, collaborative
care approach to provide comprehensive health care services to patients who use drugs, including:
a. Screening and assessing all patients for SUD, including OUD, AUD, and TUD
b. Harm reduction education including but not limited to education about overdose prevention
strategies, training on identifying and responding to an overdose, safer drug use practices; and
connections to syringe service programs, Overdose Prevention Centers, and drug-checking
services.
c. Offer and dispense naloxone kits to patients who would like one
d. Provide information to patients who use drugs about the most current options for care and
treatment of SUDs, and, as relevant, provide and discuss information about medication
treatment options to patients with OUD, AUD, and TUD.
e. Provide buprenorphine treatment for OUD, manage all aspects and phases of treatment,
including initial visit for buprenorphine treatment, buprenorphine initiation, and ongoing care
f. Connect to or directly provide medication treatment for AUD and TUD
g. Provide universal/routine testing for Hep C and HIV, and as relevant connect to or directly
provide Hep C treatment and care, PrEP/PEP, and HIV treatment and care